BLTE

Belite Bio, Inc - American Depositary Shares (BLTE)

About Belite Bio, Inc - American Depositary Shares (BLTE)

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

Details

Daily high

$59.45

Daily low

$57.99

Price at open

$59.26

52 Week High

$86.53

52 Week Low

$43.70

Market cap

1.9B

Dividend yield

0.00%

Volume

60,241

Avg. volume

49,203

P/E ratio

-43.66

Belite Bio, Inc - American Depositary Shares News